A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.
暂无分享,去创建一个
D. Brooks | A. Korczyn | O. Rascol | A. Lang | D. Brooks | P. D. De Deyn | C. Clarke | O Rascol | A E Lang | D J Brooks | C E Clarke | P P De Deyn | A D Korczyn | A. Korczyn | P. D. de Deyn | D. Pp
[1] C. Markham,et al. A double‐blind comparison of levodopa, madopa, and sinemet in Parkinson disease , 1978, Annals of neurology.
[2] O. Rascol,et al. A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[3] S Fahn,et al. Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole , 1999, Neurology.
[4] G. Broe,et al. The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[5] U. Rinne. Lisuride, a dopamine agonist in the treatment of early Parkinson's disease , 1989, Neurology.
[6] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[7] D. Brooks,et al. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study , 1998, Movement disorders : official journal of the Movement Disorder Society.
[8] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[9] U. Rinne. Combined bromocriptine‐levodopa therapy early in Parkinson's disease , 1985, Neurology.
[10] J G Nutt,et al. Levodopa‐induced dyskinesia , 1990, Neurology.
[11] A. Korczyn,et al. A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson’s disease , 1999, Neurology.
[12] W. Poewe. Should treatment of Parkinson's disease be started with a dopamine agonist? , 1998, Neurology.
[13] D. Brooks,et al. Ropinirole in the symptomatic treatment of Parkinson's disease. , 1995, Journal of neural transmission. Supplementum.
[14] W. Koller,et al. An algorithm (decision tree) for the management of Parkinson’s disease (2001): , 1998, Neurology.
[15] P. Simpson,et al. Statistical methods in cancer research , 2001, Journal of surgical oncology.
[16] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[17] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[18] M. Muenter,et al. Multi‐center study of Parkinson mortality with early versus later dopa treatment , 1987, Annals of neurology.
[19] P. Jenner,et al. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L‐dopa in the MPTP‐treated marmoset , 1998, Movement disorders : official journal of the Movement Disorder Society.
[20] W. Koller,et al. An algorithm (decision tree) for the management of Parkinson's disease , 1998, Neurology.
[21] C. Marsden,et al. Cabergoline in the treatment of early parkinson's disease , 1997, Neurology.
[22] C. Adler,et al. Ropinirole for the treatment of early Parkinson's disease , 1997, Neurology.
[23] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[24] P. Leigh,et al. Treatment of parkinsonism with bromocriptine. , 1974, Lancet.
[25] F. Gabreëls,et al. Madopar versus sinemet. A clinical study on their effectiveness. , 1975, European neurology.
[26] W. Weiner,et al. Early combination therapy with bromocriptine and levodopa in parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.
[27] O. Rascol,et al. Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study , 1998, Movement disorders : official journal of the Movement Disorder Society.
[28] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[29] S. Fahn. Levodopa-Induced Neurotoxicity , 1997 .
[30] S. Fahn,et al. A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease , 1998, Neurology.
[31] G. Block,et al. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. , 1997, European neurology.
[32] T. Chase,et al. Levodopa therapy , 1998, Neurology.
[33] S Fahn,et al. Committee. Unified Parkinson’s Disease Rating Scale. , 2001 .
[34] J. Hubble. Novel drugs for Parkinson's disease. , 1999, The Medical clinics of North America.
[35] Norman E. Breslow,et al. The design and analysis of cohort studies , 1987 .